As the United States experiences a continuous increase in cases of melanoma, researchers from the University of Tennessee Health Science Center are beginning a study to determine whether sex hormones affect the risk of the deadly skin cancer.
A study at the University of Tennessee Health Science Center aims to develop a new way to treat ischemic stroke, a leading cause of death in adults worldwide. The study is funded by a $1,155,000 translational grant from the National Institute of Neurological Disorders and Stroke, part of the National Institutes of Health. Jianxiong Jiang,… Read More
Lawrence Pfeffer, PhD, Professor in the Department of Pathology at the University of Tennessee Health Science Center, recently was awarded $2.56 million from the National Cancer Institute over the next five years to identify and target molecular pathways that will enhance glioblastoma’s sensitivity to currently approved drug therapies. Dr. Pfeffer has spent the better part of 20… Read More
The College of Pharmacy at the University of Tennessee Health Science Center is now ranked No. 6 in annual research funding from the National Institutes of Health, according to a new listing published by the American Association of Colleges of Pharmacy of its approximately 140 member institutions.
A University of Tennessee Health Science Center (UTHSC) research team is poised to make a real-world impact on vulnerable cancer patients, thanks to new support from the State of Tennessee.
UTHSC researchers working to find new treatments to combat breast cancer metastasis recently pulled in a major national award. Wei Li, PhD, distinguished professor of Pharmaceutical Sciences and director of the Drug Discovery Center in the College of Pharmacy, and Tiffany Seagroves, PhD, professor of Pathology in the College of Medicine, are principal investigators on… Read More
Researchers from the University of Tennessee Health Science Center have made a foundational discovery about chromosome biology through their work on the first-ever human pangenome reference.
This Scientific Statement expands the Society’s 2012 statement by focusing on endocrine disease disparities in the pediatric and sexual and gender minoritized populations. These include pediatric and adult lesbian, gay, bisexual, transgender, queer, intersex and asexual (LGBTQIA) people. The writing group focused on prevalent conditions such as growth disorders, puberty disorders, bone conditions, diabetes and… Read More
